Julian L Leibowitz (Julian Leibowitz)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Molecular Docking

Staphylococcus Aureus

Respiratory Syndrome Coronavirus

Multiple Sclerosis

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Maxim Lebedev, Aaron B Benjamin, Sathish Kumar, Natalia Molchanova, Jennifer S Lin, Kent J Koster, Julian L Leibowitz, Annelise E Barron, Jeffrey D Cirillo
Antiviral Effect of Antimicrobial Peptoid TM9 and Murine Model of Respiratory Coronavirus Infection. Pharmaceutics 16 (4) (2024)
Maxim Lebedev, Aaron B Benjamin, Sathish Kumar, Natalia Molchanova, Jennifer S Lin, Kent J Koster, Julian L Leibowitz, Annelise E Barron, Jeffrey D Cirillo
Antiviral Effect of Antimicrobial Peptoid TM9 and Murine Model of Respiratory Coronavirus Infection. Pharmaceutics 16 (4) (2024)
Maxim Lebedev, Aaron B Benjamin, Sathish Kumar, Natalia Molchanova, Jennifer S Lin, Kent J Koster, Julian L Leibowitz, Annelise E Barron, Jeffrey D Cirillo
Antiviral Effect of Antimicrobial Peptoid TM9 and Murine Model of Respiratory Coronavirus Infection. Pharmaceutics 16 (4) (2024)
Kelsey Michelle Wells, Kai He, Aseem Pandey, Ana Cabello, Dongmei Zhang, Jing Yang, Gabriel Gomez, Yue Liu, Haowu Chang, Xueqiang Li, Hao Zhang, Xuehuang Feng, Luciana Fachini da Costa, Richard P Metz, Charles D Johnson, Cameron Lee Martin, Jill Skrobarczyk, Luc R Berghman, Kristin L Patrick, Julian L Leibowitz, Allison Ficht, Sing-Hoi Sze, Jianxun Song, Xiaoning Qian, Qing-Ming Qin, Thomas A Ficht, Paul de Figueiredo
Brucella activates the host RIDD pathway to subvert BLOS1-directed immune defense. eLife 11 (2022)